Vascular tumors of the breast are rare, but benign hemangiomas are the most common type. Capillary hemangiomas are a subset of benign vascular tumors that involve smaller vessel sizes. They are difficult to diagnose with mammography and ultrasound, as they lack pathognomonic features and are frequently not seen. MRI is the most sensitive imaging tool. The lesions appear similar to angiosarcoma or ductal carcinoma in situ on imaging, which further complicates the diagnosis. A biopsy of the lesions is required for a definitive diagnosis. In this report, a 49-year-old female with newly diagnosed breast cancer is incidentally found to have a capillary hemangioma on staging breast MRI that was confirmed with a biopsy and excised along with the primary breast cancer with a partial mastectomy. The imaging findings of breast hemangioma on mammography, ultrasound, and MRI are also reviewed and described in this report.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11079714 | PMC |
http://dx.doi.org/10.7759/cureus.57903 | DOI Listing |
Cureus
November 2024
General Surgery, Northeast Georgia Medical Center Gainesville, Gainesville, USA.
Intraosseous hemangiomas are rare benign vascular tumors predominantly occurring in the axial skeleton. This case report describes a 44-year-old female with a history of multiple renal stones and benign breast calcifications, who was incidentally found to have a 1.2 cm lucent lesion in the left iliac bone during imaging for nephrolithiasis.
View Article and Find Full Text PDFRadiol Case Rep
January 2025
Department of Diagnostic Imaging, Fondazione Poliambulanza Hospital, Brescia, Italy.
Haemangiomas have been described in many anatomic locations, but occur quite rarely in the breast; although unfrequent, they are the most common benign vascular tumors of the breast. They are comprised in the cathegory of mesenchymal lesions, a spectrum of lesions that arise in the stroma of the breast as defined by WHO. Here we present the case of a breast haemangioma in a 40-years-old woman, with history of a palpable lump in the left breast slowly increasing in size over time.
View Article and Find Full Text PDFFront Immunol
November 2024
Department of Anesthesiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Background: Epithelioid hemangioendothelioma (EHE), is an uncommon, intermediate-grade malignant vascular tumor that can manifest in diverse organs, including the liver, lungs, and bones. Given its unique malignancy profile and rarity, there lacks a consensus on a standardized treatment protocol for EHE, particularly for hepatic epithelioid hemangioendothelioma (HEHE). This study aims to elucidate factors influencing the clinical prognosis of EHE by analyzing data from the SEER database, complemented with insights from a departmental cohort of 9 HEHE cases.
View Article and Find Full Text PDFGenes Chromosomes Cancer
September 2024
Department of Pathology and Laboratory Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
Angiosarcomas of the kidney and adrenal gland are rare, highly aggressive vascular neoplasms. Their genomic profile has not been systematically studied to date. We report the clinicopathologic and molecular features of six angiosarcomas centered in the kidney/adrenal gland.
View Article and Find Full Text PDFCurr Med Imaging
August 2024
Department of Medical Imaging, Chongqing University Fuling Hospital, Chongqing, China.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!